What is Positron's earnings per share (EPS)?

Positron (POSC) reported diluted earnings per share of $-0.34 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Positron Financials

POSC

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows Positron (POSC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

0.44x

For every $1 of reported earnings, Positron generates $0.44 in operating cash flow (-$4.7M OCF vs -$10.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-83.8x

Positron earns $-83.8 in operating income for every $1 of interest expense (-$10.5M vs $125K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$461K

YoY-68.5%

5Y CAGR-36.9%

Positron generated $461K in revenue in fiscal year 2025. This represents a decrease of 68.5% from the prior year.

EBITDA

-$10.5M

YoY-304.1%

Positron's EBITDA was -$10.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 304.1% from the prior year.

Net Income

-$10.6M

YoY-310.3%

Positron reported -$10.6M in net income in fiscal year 2025. This represents a decrease of 310.3% from the prior year.

EPS (Diluted)

$-0.34

Positron earned $-0.34 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

33M

YoY+136.6%

Positron had 33M shares outstanding in fiscal year 2025. This represents an increase of 136.6% from the prior year.

Margins & Returns

Gross Margin

-458.2%

YoY-465.3pp

5Y CAGR-459.5pp

Positron's gross margin was -458.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 465.3 percentage points from the prior year.

Operating Margin

-2275.1%

YoY-2088.0pp

5Y CAGR-1962.7pp

Positron's operating margin was -2275.1% in fiscal year 2025, reflecting core business profitability. This is down 2088.0 percentage points from the prior year.

Net Margin

-2297.8%

YoY-2121.6pp

5Y CAGR-2061.6pp

Positron's net profit margin was -2297.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2121.6 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

$2.5M

Positron spent $2.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

N/A

POSC Income Statement

Metric	FY25	FY14	FY13	FY12	FY11	FY10
Revenue	$461K-68.5%	$1.5M-10.1%	$1.6M-41.8%	$2.8M-58.0%	$6.7M+44.1%	$4.6M
Cost of Revenue	$2.6M+89.1%	$1.4M+12.9%	$1.2M-38.8%	$2.0M-69.1%	$6.4M+39.9%	$4.6M
Gross Profit	-$2.1M-2133.0%	$104K-75.5%	$424K-48.9%	$829K+199.3%	$277K+369.5%	$59K
R&D Expenses	N/A	$471K-16.5%	$564K-40.0%	$940K-28.5%	$1.3M+3.1%	$1.3M
SG&A Expenses	$8.4M+282.8%	$2.2M-21.2%	$2.8M-35.8%	$4.3M+86.8%	$2.3M-80.9%	$12.1M
Operating Income	-$10.5M-282.7%	-$2.7M+17.8%	-$3.3M+29.3%	-$4.7M-7.5%	-$4.4M+69.6%	-$14.4M
Interest Expense	$125K-93.1%	$1.8M-14.7%	$2.1M+21.9%	$1.8M+47.9%	$1.2M+2655.8%	$43K
Income Tax	N/A	$0	$0	$0	$0	N/A
Net Income	-$10.6M-310.3%	-$2.6M+63.6%	-$7.1M+10.7%	-$8.0M-30.0%	-$6.1M+44.0%	-$10.9M
EPS (Diluted)	$-0.34	N/A	N/A	N/A	N/A	N/A

Metric	Q2'16	Q1'16	Q4'15	Q3'15	Q2'15	Q1'15	Q4'14	Q3'14
Revenue	$304K-7.3%	$328K-5.2%	$346K+33.6%	$259K-34.6%	$396K+11.5%	$355K-22.1%	$456K-4.2%	$476K
Cost of Revenue	$197K+3.7%	$190K-9.5%	$210K	N/A	$392K+26.5%	$310K-27.6%	$428K	N/A
Gross Profit	$107K-22.5%	$138K+1.5%	$136K+403.7%	$27K+575.0%	$4K-91.1%	$45K+60.7%	$28K-82.9%	$164K
R&D Expenses	$2K-60.0%	$5K-95.8%	$120K	N/A	$126K+5.0%	$120K+17.6%	$102K	N/A
SG&A Expenses	$255K-23.2%	$332K-34.3%	$505K	N/A	$529K-10.3%	$590K+4.4%	$565K	N/A
Operating Income	-$170K+23.8%	-$223K+58.0%	-$531K	N/A	-$707K0.0%	-$707K-3.2%	-$685K	N/A
Interest Expense	$141K-0.7%	$142K+4.4%	$136K	N/A	$679K-7.5%	$734K+85.4%	$396K	N/A
Income Tax	$0	$0	$0	N/A	$0	$0	$0	N/A
Net Income	-$255K+32.0%	-$375K+32.3%	-$554K-744.2%	$86K+106.0%	-$1.4M-614.4%	-$201K+76.7%	-$861K-125.1%	$3.4M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

POSC Balance Sheet

Metric	FY25	FY14	FY13	FY12	FY11	FY10
Total Assets	N/A	$1.9M-51.9%	$3.9M+44.6%	$2.7M+16.3%	$2.3M-55.4%	$5.2M
Current Assets	N/A	$730K-71.6%	$2.6M+133.1%	$1.1M-43.4%	$2.0M-59.3%	$4.8M
Cash & Equivalents	N/A	$208K-88.1%	$1.7M+617.7%	$243K+24200.0%	$1K-99.9%	$1.1M
Inventory	N/A	$330K-39.7%	$547K-0.7%	$551K-25.6%	$741K+19.1%	$622K
Accounts Receivable	N/A	$175K-29.1%	$247K-9.5%	$273K-55.4%	$612K+19.1%	$514K
Goodwill	N/A	$0	$0-100.0%	$346K	N/A	N/A
Total Liabilities	N/A	$2.7M-82.1%	$15.1M+70.4%	$8.9M+71.5%	$5.2M-1.6%	$5.3M
Current Liabilities	N/A	$2.7M-81.6%	$14.7M+80.7%	$8.1M+56.7%	$5.2M-1.6%	$5.3M
Long-Term Debt	N/A	$1.1M	N/A	$689K	N/A	N/A
Total Equity	N/A	-$837K+92.6%	-$11.2M-81.6%	-$6.2M-115.8%	-$2.9M-3234.9%	-$86K
Retained Earnings	N/A	-$126.0M-2.1%	-$123.4M-6.1%	-$116.3M-7.3%	-$108.4M-6.0%	-$102.3M

Metric	Q2'16	Q1'16	Q4'15	Q3'15	Q2'15	Q1'15	Q4'14	Q3'14
Total Assets	$1.5M-7.4%	$1.6M-2.6%	$1.7M-9.8%	$1.9M-28.7%	$2.6M+12.0%	$2.3M-27.0%	$3.2M-17.4%	$3.9M
Current Assets	$514K-14.8%	$603K+1.2%	$596K-18.4%	$730K-49.1%	$1.4M+26.7%	$1.1M-41.4%	$1.9M-25.0%	$2.6M
Cash & Equivalents	$28K-68.5%	$89K+12.7%	$79K-62.0%	$208K-73.6%	$787K+110.4%	$374K-68.3%	$1.2M-32.5%	$1.7M
Inventory	$316K-1.6%	$321K-2.7%	$330K0.0%	$330K-19.1%	$408K-23.7%	$535K+13.8%	$470K-14.1%	$547K
Accounts Receivable	$147K-13.5%	$170K+3.7%	$164K-6.3%	$175K-23.9%	$230K+7.5%	$214K-13.7%	$248K+0.4%	$247K
Goodwill	N/A	N/A	N/A	$0	N/A	N/A	N/A	$0
Total Liabilities	$3.1M+4.5%	$3.0M+12.6%	$2.6M-2.5%	$2.7M-11.0%	$3.0M-54.5%	$6.7M-56.3%	$15.3M+1.2%	$15.1M
Current Liabilities	$3.1M+4.5%	$3.0M+12.9%	$2.6M-2.5%	$2.7M-11.3%	$3.0M-54.5%	$6.7M-20.4%	$8.4M-42.7%	$14.7M
Long-Term Debt	N/A	N/A	$1.0M-4.0%	$1.1M	N/A	N/A	$1.4M	N/A
Total Equity	-$1.6M-19.2%	-$1.3M-39.3%	-$953K-13.9%	-$837K-99.3%	-$420K+90.3%	-$4.3M+64.1%	-$12.1M-7.7%	-$11.2M
Retained Earnings	-$127.2M-0.2%	-$126.9M-200.3%	$126.6M+200.4%	-$126.0M-0.1%	-$125.9M0.0%	-$125.9M-1.3%	-$124.3M-0.7%	-$123.4M

POSC Cash Flow Statement

Metric	FY25	FY14	FY13	FY12	FY11	FY10
Operating Cash Flow	-$4.7M-94.6%	-$2.4M+20.7%	-$3.0M-36.0%	-$2.2M+45.0%	-$4.1M+13.1%	-$4.7M
Capital Expenditures	N/A	$26K+62.5%	$16K-78.1%	$73K+630.0%	$10K-95.8%	$238K
Free Cash Flow	N/A	-$2.4M+20.3%	-$3.1M-32.4%	-$2.3M+43.4%	-$4.1M+17.1%	-$4.9M
Investing Cash Flow	-$99K	N/A	-$16K+77.8%	-$72K-620.0%	-$10K+95.8%	-$238K
Financing Cash Flow	$7.3M	N/A	$4.6M+78.7%	$2.6M-13.3%	$2.9M-50.2%	$5.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$2.5M	N/A	N/A	N/A	N/A	N/A

Metric	Q2'16	Q1'16	Q4'15	Q3'15	Q2'15	Q1'15	Q4'14	Q3'14
Operating Cash Flow	-$48K+70.2%	-$161K+52.1%	-$336K+36.8%	-$532K-5.8%	-$503K+26.6%	-$685K+1.4%	-$695K+26.6%	-$947K
Capital Expenditures	$0	$0	$0-100.0%	$1K-94.1%	$17K+183.3%	$6K+200.0%	$2K	$0
Free Cash Flow	-$48K+70.2%	-$161K+52.1%	-$336K+37.0%	-$533K-2.5%	-$520K+24.7%	-$691K+0.9%	-$697K+26.4%	-$947K
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	-$2K	$0
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	$131K-94.7%	$2.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

POSC Financial Ratios

Metric	FY25	FY14	FY13	FY12	FY11	FY10
Gross Margin	-458.2%-465.3pp	7.1%-18.9pp	26.0%-3.6pp	29.6%+25.4pp	4.2%+2.9pp	1.3%
Operating Margin	-2275.1%-2088.0pp	-187.1%+17.7pp	-204.8%-36.2pp	-168.6%-102.7pp	-65.9%+246.5pp	-312.4%
Net Margin	-2297.8%-2121.6pp	-176.3%+259.6pp	-435.8%-151.8pp	-284.0%-192.1pp	-91.9%+144.4pp	-236.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-138.3%+44.7pp	-183.0%+113.3pp	-296.3%-31.1pp	-265.2%-54.1pp	-211.2%
Current Ratio	N/A	0.27+0.1	0.18+0.0	0.14-0.2	0.38-0.5	0.91
Debt-to-Equity	N/A	-1.28+0.1	-1.35-1.2	-0.11+1.7	-1.80+59.3	-61.15
FCF Margin	N/A	-166.5%+21.3pp	-187.8%-105.3pp	-82.6%-21.3pp	-61.3%+45.2pp	-106.5%

Metric	Q2'16	Q1'16	Q4'15	Q3'15	Q2'15	Q1'15	Q4'14	Q3'14
Gross Margin	35.2%-6.9pp	42.1%+2.8pp	39.3%+28.9pp	10.4%+9.4pp	1.0%-11.7pp	12.7%+6.5pp	6.1%-28.3pp	34.4%
Operating Margin	-55.9%+12.1pp	-68.0%+85.5pp	-153.5%	N/A	-178.5%+20.6pp	-199.2%-48.9pp	-150.2%	N/A
Net Margin	-83.9%+30.4pp	-114.3%+45.8pp	-160.1%-193.3pp	33.2%+395.8pp	-362.6%-306.0pp	-56.6%+132.2pp	-188.8%-908.4pp	719.5%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-16.8%+6.1pp	-22.8%+10.0pp	-32.9%-37.5pp	4.6%+59.4pp	-54.8%-46.2pp	-8.6%+18.3pp	-26.9%-115.1pp	88.2%
Current Ratio	0.17-0.0	0.20-0.0	0.23-0.0	0.27-0.2	0.47+0.3	0.17-0.1	0.23+0.1	0.18
Debt-to-Equity	-1.96+0.3	-2.24-1.2	-1.08+0.2	-1.28+6.0	-7.24-5.7	-1.54-1.4	-0.12+1.2	-1.35
FCF Margin	-15.8%+33.3pp	-49.1%+48.0pp	-97.1%+108.7pp	-205.8%-74.5pp	-131.3%+63.3pp	-194.6%-41.8pp	-152.8%+46.1pp	-199.0%

Similar Companies

Cannabix Technol BLOZF

$64.6M

Acarix AB ACIXF

$33.8M

Vivos RDGL

$38.3M

Theralase Technologies Inc TLTFF

$55.6M

Guided Thera GTHP

$22.1M

Frequently Asked Questions

What is Positron's annual revenue?

Positron (POSC) reported $461K in total revenue for fiscal year 2025. This represents a -68.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Positron's revenue growing?

Positron (POSC) revenue declined by 68.5% year-over-year, from $1.5M to $461K in fiscal year 2025.

Is Positron profitable?

No, Positron (POSC) reported a net income of -$10.6M in fiscal year 2025, with a net profit margin of -2297.8%.

What is Positron's EBITDA?

Positron (POSC) had EBITDA of -$10.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Positron's gross margin?

Positron (POSC) had a gross margin of -458.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Positron's operating margin?

Positron (POSC) had an operating margin of -2275.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Positron's net profit margin?

Positron (POSC) had a net profit margin of -2297.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Positron's operating cash flow?

Positron (POSC) generated -$4.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Does Positron buy back shares?

Yes, Positron (POSC) spent $2.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Positron have outstanding?

Positron (POSC) had 33M shares outstanding as of fiscal year 2025.

Are Positron's earnings high quality?

Positron (POSC) has an earnings quality ratio of 0.44x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Positron cover its interest payments?

Positron (POSC) has an interest coverage ratio of -83.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.